Employers search

About Us

Aspen Neuroscience is a clinical-stage regenerative medicine biotechnology company developing autologous induced pluripotent stem cell (iPSC)-derived therapies, beginning with Parkinson’s disease (PD). Our lead investigational therapy, sasineprocel (ANPD001), is designed to replace lost dopaminergic neurons and reconstruct the underlying neural circuitry to restore function and potentially slow disease progression—without the need for immunosuppression.

At Aspen, our team is passionate about bringing our world class science and manufacturing to patients. We aim to transform the lives of people living with PD with our personalized regenerative therapies that offer real hope where none existed before.